$33.290
+0.130 (+0.39%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GMAB por análisis de gráficos similares
Alphio's GMAB stock price prediction model matches the current Genmab A/S tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $33.32 (+0.09%). The 1-week path is $33.45 (+0.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Genmab A/S?
Genmab A/S (GMAB) is a good buy right now, trading at $33.23 with a forward P/E of 20.62, which is attractive compared to its growth potential. The stock has shown a strong 1-year change of +28.35%, indicating solid performance. Analyst targets suggest a potential upside, with Guggenheim setting a target of $42 and TD Cowen at $43, both reflecting confidence in the company's future despite recent challenges. The main risk is the recent trial failure of Epcoritamab, which could impact market acceptance and sales, but the stock's current valuation and growth prospects outweigh this concern.
GMAB cerró en $33.29 el Tuesday, tras subir +0.39%
Genmab A/S (GMAB) last closed at $33.29, gaining +0.39%. These facts feed the 1-day and 1-week GMAB price prediction above.
Factores de la previsión
Los factores de la previsión de Genmab A/S (GMAB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GMAB, ordenadas por similitud.
Análisis de estacionalidad de GMAB
Historically the probability of a positive September return for GMAB is 53.49%. September offers the highest probability of a positive month at 53.49%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GMAB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $25.46 | $26.73 | $31.18 | -19.71% |
| Oct 2026 | $17.30 | $21.62 | $22.57 | -35.05% |
| Nov 2026 | $28.07 | $28.69 | $33.47 | -13.81% |
| Dec 2026 | $24.17 | $24.45 | $26.55 | -26.56% |
En 2026, se proyecta que Genmab A/S (GMAB) oscile entre $17.30 y $33.47.
Previsión mensual de Genmab A/S para 2026
En Sep de 2026, se proyecta que Genmab A/S promedie $26.73, con un mínimo de $25.46 y un máximo de $31.18.
En Oct de 2026, se proyecta que Genmab A/S promedie $21.62, con un mínimo de $17.30 y un máximo de $22.57.
En Nov de 2026, se proyecta que Genmab A/S promedie $28.69, con un mínimo de $28.07 y un máximo de $33.47.
En Dec de 2026, se proyecta que Genmab A/S promedie $24.45, con un mínimo de $24.17 y un máximo de $26.55.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.